US

Roger L Kaspar

This inventor holds 0 USPTO granted patents, plus 4 CIPO patents.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Roger L Kaspar. Retrieved from https://idiyas.com/inventor/roger-l-kaspar-0y9bs4rf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

 

Average Co-Inventor Count = 1.0

ph-index = 1


Loading Chart...

Title: Roger L. Kaspar: Innovator in Transdermal Delivery Systems

Introduction

Roger L. Kaspar is a notable inventor based in the United States, recognized for his contributions to the field of transdermal delivery systems. With a focus on innovative formulations and devices, he has made significant strides in the delivery of mTOR inhibitors through his patented inventions.

Latest Patents

Roger L. Kaspar holds two notable patents. The first patent, titled "Compositions For Transdermal Delivery Of Mtor Inhibitors," presents formulations designed for the transdermal delivery of rapamycin and related compounds. This invention includes a combination of an mTOR inhibitor, water, surfactant polymers, thickening polymers, solvents, glycols, C10-C20 fatty acids, and a base. The second patent, "Microneedle Arrays Formed From Polymer Films," provides transdermal delivery devices featuring microneedle arrays. This device includes a polymer layer with microneedles that are compositionally homogeneous with the polymer base layer.

Career Highlights

Throughout his career, Roger L. Kaspar has worked with several companies, including Transderm, Inc. and Palvella Therapeutics, Inc. His work has focused on advancing the technology behind transdermal delivery systems, contributing to the development of innovative medical solutions.

Collaborations

Roger has collaborated with various professionals in his field, including Tycho Speaker, to enhance the effectiveness and application of his inventions.

Conclusion

Roger L. Kaspar's work in transdermal delivery systems showcases his commitment to innovation in the medical field. His patents reflect a deep understanding of formulation science and device engineering, paving the way for future advancements in drug delivery methods.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…